BCR::ABL1 tyrosine kinase inhibitors induce ribosome collisions to activate ZAK-dependent ribotoxic stress and apoptosis in chronic myeloid leukemia. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.